Navigation Links
British Study Supports Mammograms for Some Women Under 50

By Maureen Salamon
HealthDay Reporter

THURSDAY, Nov. 18 (HealthDay News) -- Mammograms given to women under 50 with a moderate family history of breast cancer can spot cancers earlier and increase the odds for long-term survival, a new study shows.

British researchers examined mammogram results for 6,710 women with several relatives with breast cancer, or at least one relative diagnosed before age 40, finding that 136 were diagnosed with the malignancy between 2003 and 2007.

These women, who researchers said were probably not carriers of a mutated BRCA breast cancer gene, started receiving mammograms at an earlier age than recommended by the U.K. National Health Service, which currently offers the screenings every three years for women between the ages of 50 and 70.

Findings showed their tumors were smaller and less aggressive than those in women screened at typical ages, and these women were more likely to be alive 10 years after diagnosis of an invasive cancer, the researchers said.

"We were not entirely surprised at the findings," said lead researcher Stephen Duffy, a professor of cancer screening at Barts and The London School of Medicine and Dentistry at Queen Mary University of London.

"There is already evidence that population screening with mammography works in women under 50, even if it is somewhat less effective than at later ages. However, there is evidence that women with a family history have denser breast tissue, which makes mammography a tougher job, so we were not sure what to expect," Duffy noted.

"We did not explicitly exclude BRCA-positive women," he added, "but very few with an identified mutation were recruits, and because the women had a moderate rather than an extensive family history, we suspect there were very few cases among the vast majority who had not been tested for mutations."

Duffy juxtaposed his findings against the current debate among U.S. public health experts, who disagree over whether annual mammograms are necessary beginning at the age of 40, which has been the standard for years. In November 2009, the U.S. Preventive Services Task Force sparked outrage when it revised its mammogram recommendations, suggesting that screenings can wait until age 50 and be given every other year.

"There are two issues here," Duffy said. "The first is that there is some evidence of a mortality benefit of screening women in their 40s, albeit a lesser one than in older women. The second is that our study does not relate to population screening, but to mammographic surveillance of women who [are concerned] about their family history of breast or ovarian cancer," he explained.

"This latter issue is less controversial," he added. "There is a debate in the U.K. about the age to start screening the general population, although there is less controversy about surveillance earlier in life for women with a family history of breast cancer."

The study, published online Nov. 18 in The Lancet Oncology, enrolled women from 76 health centers across 34 cancer research networks, 91 percent of whom were between the ages of 40 and 44 at the start. The women's average age was 42, and slightly less than half had a relative with breast cancer diagnosed at younger than age 40.

About 77 percent of the breast cancer cases diagnosed during the study were detected at screening, giving the early mammograms a 79 percent sensitivity rate. Researchers predicted an 81 percent average 10-year survival rate among participants, while survival rates for those in control groups were forecasted at no more than 73 percent.

Marc Schwartz, an associate professor of oncology at Georgetown University Medical Center, said the study is important because it examines a group at increased breast cancer risk for whom there are no tailored screening guidelines. Similarly, he said, this group's risk is not high enough to warrant the management options typically given to BRCA carriers.

"Research like this provides our best evidence . . . for making policy decisions about screening for this group," said Schwartz, who is also co-director of Georgetown's Jess and Mildred Fisher Center for Familial Cancer Research at Lombardi Comprehensive Cancer Center.

"However, as the authors point out, the results must be interpreted cautiously," he added. "This study cannot be considered definitive. The authors do not report on actual mortality outcomes; rather, they calculated expected mortality based on the size . . . and grade of the tumors that were identified. They then compared this to similar estimates from non-screened, unmatched, control groups from prior studies."

More information

Head to the American Cancer Society for details on its breast cancer screening guidelines.

SOURCES: Stephen Duffy, professor, cancer screening, Barts and The London School of Medicine and Dentistry, Queen Mary University of London; Marc Schwartz, Ph.D., director, cancer control program and co-director, Jess and Mildred Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, and associate professor, oncology, Georgetown University Medical Center, Washington, D.C.; Nov. 18, 2010, The Lancet Oncology, online

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Older Americans Sicker Than British Peers...
2. Super Fitness Bikini Model Mega-Mogul Jennifer Nicole Lee Goes Global, British TV Appearance, QVC London May 12th Sharing Top Fitness Products
3. British Safety Council Offers Free Health and Safety Qualifications
4. DTM Systems Corporation Ranked Number One as the Largest Reseller in British Columbia to Hewlett Packard Canada
5. Spleen Cells Tied to Damage of Spinal Cord Injury in Animal Study
6. Undergrads Who Twitter May Do Better, Study Finds
7. HIV Patients Do Well After Kidney Transplants: Study
8. Lung cancer patients are the centerpiece for Northwestern medicine quality of care study
9. Study Reports More Precise Way to Remove Cataracts
10. Long-Term Statin Use Wont Up Cancer Risk: Study
11. Toronto Western Hospital study demonstrates improved wait times for patients suffering back pain
Post Your Comments:
Related Image:
British Study Supports Mammograms for Some Women Under 50
(Date:11/26/2015)... ... November 26, 2015 , ... Inevitably when people think Thanksgiving, ... choose to buy during the Black Friday and Cyber Monday massage chair sales ... search the Internet high and low to find the best massage chair deals, they ...
(Date:11/26/2015)... ... November 26, 2015 , ... PRMA Plastic Surgery is updating their ... surgeons performed their 6,000th free flap breast reconstruction surgery! , “What an accomplishment for ... excited to rebuild lives and it’s an honor to have served all of these ...
(Date:11/25/2015)... ... November 25, 2015 , ... Additional breast cancers found with ... according to a study published online in the journal Radiology. Researchers said that ... necessitate a change in treatment. , Breast MRI is the most sensitive technique ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... factory direct sauna parts and accessories. , Sauna accessories help improve the bather ... style and personality. From basic styles for the purist looking for simplicity in ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an article published ... and more widely heralded as a breakthrough for performing hernia repairs. The article explains ... laparoscopic surgery is that it can greatly reduce the pain that a patient might ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)...  The total global healthcare industry is expected to grow ... Latin America has the highest projected growth at ... Japan ), is second with growth projected at 11.5%. ... healthcare expenditure. In 2013-2014, total government funded healthcare was nearly ... to 41.2% in 2013-2014. In real terms, out of pocket ...
(Date:11/25/2015)... , Nov. 25, 2015 AAIPharma Services ... investment of at least $15.8  Million to expand ... Wilmington, NC . The expansion will provide ... meet the growing demands of the pharmaceutical and ... site expansion will provide up to 40,000 square ...
(Date:11/25/2015)... Israel , November 25, 2015 ... KTOV ) (TASE: KTOV), a biopharmaceutical company focused ... treatment of various clinical conditions, today announced the closing ... American Depository Shares ( ADSs ), each representing 20 ... up to 3,158,900 ADSs. The ADSs and warrants were ...
Breaking Medicine Technology: